June 1, 2023 - Sanofi

07/28/2020 – Policy Notice

02/01/2021 – Policy Update

06/01/2023 – Policy Notice

Can CE get 340B pricing if they share claims data?


Are system owned contract pharmacies exempted from this policy?


Can CEs with no in-house pharmacy designate a contract pharmacy for 340B pricing access?

Yes (no mileage restriction)

Drugs affected by this policy:

Adlyxin™ Admelog™ Amaryl™ Ambien™ Apidra™ Arava™ Avalide™ Avapro™ Doxercalciferol™ Dupixent Enoxaparin Sodium™ Flomax™ Insulin Glargine™ Ibesartan™ Kevzara™ Lantus™ Leflunomide™ Lovenox™ Multaq™ Plavix™ Priftin™ Primaquine™ Renagel™ Renvela™ Sevelamer™ Soliqua™ Toujeo™ Zolpidem™

Policy applies to what entity types?

New policy applies to CAHs, DSH, RRCs and SCHs only. Consolidated Health centers can get access to unlimited number of contract pharmacies if they share data with ESP. Federal grantees are exempted from this policy